Search - tctmd.com

Displaying 121 - 140 of 638

Sort: Relevancy | Date

Presentation TCT 2020

ISCHEMIA in Perspective: Updated Meta-Analysis on PCI in SIHD

Presenter: Sripal Bangalore

October 15, 2020

Presentation TCT 2020

Natural Vascular Scaffolding for PVD Interventions (Alucent)

Presenter: Myles Greenberg

October 15, 2020

Presentation TCT 2020

Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: the SCOPE II randomised clinical trial

Presenter: Corrado Tamburino

October 15, 2020

Presentation TCT 2020

Critical Analysis and Clinical Implications From ISCHEMIA

Presenter: David Maron

October 15, 2020

Presentation TCT 2020

Yes! With the Right Training, Everyone Can (and Should) Do CTO PCI!

Presenter: Simon Walsh

October 15, 2020

Presentation TCT 2020

A Universal Nomenclature for CTO Terminology and Standardization of CTO PCI Trials: Introduction to CTO-ARC

Presenter: Luiz Ybarra

October 15, 2020

Presentation TCT 2020

Debate 2: Should CTO PCI Be Performed at Most Centers and by Most Operators? - No! CTO PCI Should Only Be Done by the Experts!

Presenter: Gerald Werner

October 15, 2020

Presentation TCT 2020

Device-Based Approaches to Infarct Size Reduction

Presenter: Giovanni Luigi De Maria

October 15, 2020

Presentation TCT 2020

Heart Valve Collaboratory Is Next in Line

Presenter: Michael Mack

October 14, 2020

Presentation TCT 2020

LAA Debate: Should LAA Closure Be Widely Adopted? - Epicardial LAA Closure (Lariat): Combining Rhythm Control & Stroke Prevention?

Presenter: Andrea Natale

October 14, 2020

Presentation TCT 2020

LAA Debate: Should LAA Closure Be Widely Adopted? - Absolutely: The Evidence for LAA Closure Is Overwhelming!

Presenter: David Holmes Jr

October 14, 2020

News Conference News TCT 2020

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

Shelley Wood

October 14, 2020

Presentation TCT 2020

Pascal

Presenter: Robert Smith

October 14, 2020

Presentation TCT 2020

Special Lecture: The "Pragmatic" Clinical Trial – A Brave New World or a Bridge Too Far!

Presenter: Robert Yeh

October 14, 2020

Presentation TCT 2020

Grading FMR Severity: Evolution of the Concept and Evolving Data

Presenter: Paul Grayburn

October 14, 2020

Presentation TCT 2020

MitraClip for FMR - New Insights From COAPT

Presenter: Gregg Stone

October 14, 2020

Presentation TCT 2020

MitraClip for Intermediate Risk DMR - REPAIR MR Trial Design and Controversies

Presenter: Patrick McCarthy

October 14, 2020

Presentation TCT 2020

TEER Technology Updates - G4 MitraClip

Presenter: Matthew Price

October 14, 2020

News Conference News TCT 2020

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

Caitlin E. Cox

October 14, 2020

Presentation TCT 2020

Robot-Assisted PCI as a Strategy to Reduce the Risk of Intra-Procedure Contamination by COVID-19 and Other Respiratory Viruses

Presenter: Pedro Lemos

October 14, 2020

Advertisement

ISCHEMIA in Perspective: Updated Meta-Analysis on PCI in SIHD

Natural Vascular Scaffolding for PVD Interventions (Alucent)

Comparison of self-expanding bioprostheses for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: the SCOPE II randomised clinical trial

Critical Analysis and Clinical Implications From ISCHEMIA

Yes! With the Right Training, Everyone Can (and Should) Do CTO PCI!

A Universal Nomenclature for CTO Terminology and Standardization of CTO PCI Trials: Introduction to CTO-ARC

Debate 2: Should CTO PCI Be Performed at Most Centers and by Most Operators? - No! CTO PCI Should Only Be Done by the Experts!

Device-Based Approaches to Infarct Size Reduction

Heart Valve Collaboratory Is Next in Line

LAA Debate: Should LAA Closure Be Widely Adopted? - Epicardial LAA Closure (Lariat): Combining Rhythm Control & Stroke Prevention?

LAA Debate: Should LAA Closure Be Widely Adopted? - Absolutely: The Evidence for LAA Closure Is Overwhelming!

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

Pascal

Special Lecture: The "Pragmatic" Clinical Trial – A Brave New World or a Bridge Too Far!

Grading FMR Severity: Evolution of the Concept and Evolving Data

MitraClip for FMR - New Insights From COAPT

MitraClip for Intermediate Risk DMR - REPAIR MR Trial Design and Controversies

TEER Technology Updates - G4 MitraClip

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

Robot-Assisted PCI as a Strategy to Reduce the Risk of Intra-Procedure Contamination by COVID-19 and Other Respiratory Viruses

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content